These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8198988)

  • 1. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours.
    Cromme FV; van Bommel PF; Walboomers JM; Gallee MP; Stern PL; Kenemans P; Helmerhorst TJ; Stukart MJ; Meijer CJ
    Br J Cancer; 1994 Jun; 69(6):1176-81. PubMed ID: 8198988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.
    Cromme FV; Airey J; Heemels MT; Ploegh HL; Keating PJ; Stern PL; Meijer CJ; Walboomers JM
    J Exp Med; 1994 Jan; 179(1):335-40. PubMed ID: 8270878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression.
    Keating PJ; Cromme FV; Duggan-Keen M; Snijders PJ; Walboomers JM; Hunter RD; Dyer PA; Stern PL
    Br J Cancer; 1995 Aug; 72(2):405-11. PubMed ID: 7640226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma.
    Vora AR; Rodgers S; Parker AJ; Start R; Rees RC; Murray AK
    Br J Cancer; 1997; 76(7):836-44. PubMed ID: 9328140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas.
    Feenstra M; Veltkamp M; van Kuik J; Wiertsema S; Slootweg P; van den Tweel J; de Weger R; Tilanus M
    Tissue Antigens; 1999 Sep; 54(3):235-45. PubMed ID: 10519360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway.
    Teisserenc H; Schmitt W; Blake N; Dunbar R; Gadola S; Gross WL; Exley A; Cerundolo V
    Immunol Lett; 1997 Jun; 57(1-3):183-7. PubMed ID: 9232449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
    Korkolopoulou P; Kaklamanis L; Pezzella F; Harris AL; Gatter KC
    Br J Cancer; 1996 Jan; 73(2):148-53. PubMed ID: 8546899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer.
    Kaklamanis L; Leek R; Koukourakis M; Gatter KC; Harris AL
    Cancer Res; 1995 Nov; 55(22):5191-4. PubMed ID: 7585572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple mechanisms underlie HLA dysregulation in cervical cancer.
    Brady CS; Bartholomew JS; Burt DJ; Duggan-Keen MF; Glenville S; Telford N; Little AM; Davidson JA; Jimenez P; Ruiz-Cabello F; Garrido F; Stern PL
    Tissue Antigens; 2000 May; 55(5):401-11. PubMed ID: 10885560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers.
    Ryu KS; Lee YS; Kim BK; Park YG; Kim YW; Hur SY; Kim TE; Kim IK; Kim JW
    Exp Mol Med; 2001 Sep; 33(3):136-44. PubMed ID: 11642549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area.
    Heeren AM; de Boer E; Bleeker MC; Musters RJ; Buist MR; Kenter GG; de Gruijl TD; Jordanova ES
    Oncotarget; 2015 Oct; 6(32):32484-93. PubMed ID: 26431490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.
    Ferns DM; Heeren AM; Samuels S; Bleeker MCG; de Gruijl TD; Kenter GG; Jordanova ES
    J Immunother Cancer; 2016; 4():78. PubMed ID: 27895918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis.
    Redondo M; García J; Villar E; Rodrigo I; Perea-Milla E; Serrano A; Morell M
    Hum Pathol; 2003 Dec; 34(12):1283-9. PubMed ID: 14691914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease.
    Tooyama I; Kimura H; Akiyama H; McGeer PL
    Brain Res; 1990 Jul; 523(2):273-80. PubMed ID: 2400911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma.
    Nouri AM; Smith ME; Crosby D; Oliver RT
    Br J Cancer; 1990 Oct; 62(4):603-6. PubMed ID: 1699592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression.
    Seliger B; Hohne A; Knuth A; Bernhard H; Meyer T; Tampe R; Momburg F; Huber C
    Cancer Res; 1996 Apr; 56(8):1756-60. PubMed ID: 8620489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis.
    Bandoh N; Ogino T; Katayama A; Takahara M; Katada A; Hayashi T; Harabuchi Y
    Oncol Rep; 2010 Apr; 23(4):933-9. PubMed ID: 20204276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
    Cordon-Cardo C; Fuks Z; Drobnjak M; Moreno C; Eisenbach L; Feldman M
    Cancer Res; 1991 Dec; 51(23 Pt 1):6372-80. PubMed ID: 1933900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and genetic analysis of transporter associated with antigen processing in cervical carcinoma.
    Vermeulen CF; Jordanova ES; ter Haar NT; Kolkman-Uljee SM; de Miranda NF; Ferrone S; Peters AA; Fleuren GJ
    Gynecol Oncol; 2007 Jun; 105(3):593-9. PubMed ID: 17382375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.